ESC 2021 HF

2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure (with 2023 Focused Update)

The 2021 ESC heart-failure guideline established the four foundational drug classes for HFrEF (ARNI/ACE inhibitor, beta-blocker, MRA and SGLT2 inhibitor), and the 2023 Focused Update extended SGLT2 inhibitors across the whole ejection-fraction spectrum. This page groups the register's landmark trials by the guideline's themes — foundational therapy, HFpEF, devices and advanced HF.

This guideline cites 26 of the 199 landmark trials in our Cardiology register.

Source
McDonagh TA, Metra M, et al. Eur Heart J. 2021;42(36):3599–3726. Focused Update: Eur Heart J. 2023;44(37):3627–3639. · European Heart Journal

Foundational HFrEF therapy (four pillars)11

  • 2020EMPEROR-ReducedCardiology · HF · SGLT2 inhibitorsEmpagliflozin Outcome Trial in Chronic Heart Failure With Reduced EF
  • 2019DAPA-HFCardiology · HF · SGLT2 inhibitorsDapagliflozin and Prevention of Adverse outcomes in Heart Failure
  • 2014PARADIGM-HFCardiology · HF · ARNIProspective comparison of ARNI with ACEI to Determine Impact on Global Mortality
  • 2011EMPHASIS-HFCardiology · HF · MRAEplerenone in Mild Patients Hospitalisation and Survival Study in Heart Failure
  • 2004A-HeFTCardiology · HF · hydralazine/nitrateAfrican-American Heart Failure Trial
  • 2003CHARMCardiology · HF · ARBCandesartan in Heart failure: Assessment of Reduction in Mortality and morbidity — Overall Programme
  • 2001COPERNICUSCardiology · HF · beta-blockerCarvedilol Prospective Randomized Cumulative Survival Study
  • 1999RALESCardiology · HF · MRARandomized Aldactone Evaluation Study
  • 1999MERIT-HFCardiology · HF · Beta-blockadeMetoprolol CR/XL Randomized Intervention Trial in Heart Failure
  • 1991SOLVDCardiology · HF · ACE inhibitorStudies of Left Ventricular Dysfunction — Treatment Trial
  • 1987CONSENSUSCardiology · HF · RAAS inhibitionCooperative North Scandinavian Enalapril Survival Study

HFmrEF & HFpEF3

  • 2022DELIVERCardiology · HF · SGLT2 inhibitorsDapagliflozin Evaluation to Improve the Lives of Patients with Preserved-EF Heart Failure
  • 2021EMPEROR-PreservedCardiology · HF · SGLT2 inhibitorsEmpagliflozin Outcome Trial in Patients With Chronic Heart Failure With Preserved EF
  • 2014TOPCATCardiology · HF · MRATreatment of Preserved Cardiac Function Heart Failure with an Aldosterone Antagonist

Adjunctive & advanced HFrEF5

  • 2022STRONG-HFCardiology · HF · GDMT up-titrationSafety, Tolerability and Efficacy of Rapid Optimization, helped by NT-proBNP testinG, of Heart Failure therapies
  • 2020VICTORIACardiology · HF · sGC stimulatorVericiguat Global Study in Subjects with Heart Failure with Reduced Ejection Fraction
  • 2019PIONEER-HFCardiology · HF · ARNIComparison of Sacubitril/Valsartan versus Enalapril on Effect on NT-proBNP in Patients Stabilized from an Acute Heart Failure Episode
  • 2016STICHCardiology · HF · CABGSurgical Treatment for Ischemic Heart Failure — Extension Study (STICHES, 10-year follow-up)
  • 2010SHIFTCardiology · HF · If-channel inhibitorSystolic Heart failure treatment with the If inhibitor ivabradine Trial

Device therapy — ICD & CRT7

  • 2016DANISHCardiology · Arrhythmia · ICDDanish Study to Assess the Efficacy of ICDs in Non-Ischaemic Systolic Heart Failure
  • 2010RAFTCardiology · Arrhythmia · CRTResynchronization-Defibrillation for Ambulatory Heart Failure Trial
  • 2009MADIT-CRTCardiology · Arrhythmia · CRTMulticenter Automatic Defibrillator Implantation Trial with CRT
  • 2005CARE-HFCardiology · Arrhythmia · CRTCardiac Resynchronisation in Heart Failure
  • 2005SCD-HeFTCardiology · Arrhythmia · ICDSudden Cardiac Death in Heart Failure Trial
  • 2004COMPANIONCardiology · Arrhythmia · CRTComparison of Medical Therapy, Pacing, and Defibrillation in Heart Failure
  • 2002MADIT-IICardiology · Arrhythmia · ICDMulticenter Automatic Defibrillator Implantation Trial II

Published since the guideline1

  • 2024FINEARTS-HFCardiology · HF · MRAFinerenone in Heart Failure with Mildly Reduced or Preserved Ejection Fraction